✦ LIBER ✦

Survivals and predictive factors of metastatic hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

✍ Scribed by Prajapati, H.J.; El-Rayes, B.; Kauh, J.; Spivey, J.R.; Hanish, S.I.; Kim, H.S.

Book ID: 122412540
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 99 KB
Volume: 24
Category: Article
ISSN: 1051-0443
DOI: 10.1016/j.jvir.2013.01.431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abstract No. 245: Survivals and predicti

Abstract No. 245: Survivals and predictive factors of metastatic hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

✍ Prajapati, H.J.; Rafi, S.; El-Rayes, B.; Kauh, J.; Kim, H.S. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Survivals and predictive factors of atyp

Survivals and predictive factors of atypical unresectable hepatocellular carcinoma (MHCC) treated with doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE)

✍ Prajapati, H.J.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; Kim, H.S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Abstract No. 244: Survival outcomes of d

Abstract No. 244: Survival outcomes of doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE) for advanced hepatocellular carcinoma (HCC)

✍ Prajapati, H.J.; Dhanasekaran, R.; El-Rayes, B.; Kauh, J.; Maithel, S.K.; Kim, H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Doxorubicin drug eluting beads transcath

Doxorubicin drug eluting beads transcatheter chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC): Survival outcomes and factors predicting survival outcomes in a 366-patient cohort

✍ Prajapati, H.J.; Webber, G.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Comparison of conventional transarterial

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

✍ Renumathy Dhanasekaran; David A. Kooby; Charles A. Staley; John S. Kauh; Vinit K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## Background and Objectives Chemoembolization with doxorubicin drug eluting beads (DEB) is a novel locoregional treatment modality for unresectable hepatocellular carcinoma (HCC). Initial animal studies and clinical trials suggest that treatment with DEB may provide safer and more eff

Abstract No. 239: Magnetic resonance ima

Abstract No. 239: Magnetic resonance imaging biomarkers predicting survivals after doxorubicin drug eluting beads transarterial chemoembolization (DEB TACE) in patients with unresectable hepatocellular carcinoma (HCC)

✍ Prajapati, H.J.; Spivey, J.R.; Hanish, S.I.; El-Rayes, B.; Kauh, J.; Kim, H.S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB